INCREMENTAL RISK OF ADVERSE EVENTS WITH ORAL JANUS KINASE INHIBITOR USE IN ATOPIC DERMATITIS AND OTHER INDICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Schneider, Shannon [1 ]
Ryttig, Lasse [2 ]
Nikodem, Mateusz [3 ]
Panek, Malgorzata [3 ]
Chudzik, Kamila [3 ]
Dament-Ko, Magdalena [3 ]
Brandi, Henrik [2 ]
机构：
[1] Leo Pharma Us, Madison, WI USA
[2] Leo Pharma AS, Copenhagen, Denmark
[3] Putnam PHMR, Krakow, Poland
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P5.7
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] The risk of infections with janus kinase inhibitor treatment for atopic dermatitis: a systematic review and meta-analysis
    Tarafdar, N.
    Sachdeva, M.
    Dubale, N.
    Smythe, C.
    Lytvyn, Y.
    Maliyar, K.
    Georgakopoulos, J.
    Mufti, A.
    Yeung, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S338 - S338
  • [2] Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis
    Ertus, Cecile
    Scailteux, Lucie-Marie
    Lescoat, Alain
    Berthe, Pauline
    Auffret, Vincent
    Dupuy, Alain
    Oger, Emmanuel
    Droitcourt, Catherine
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : 368 - 380
  • [3] MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS TREATED WITH ORAL JANUS KINASE INHIBITORS FOR ATOPIC DERMATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ertus, Cecile
    Scailteux, Lucie-Marie
    Lescoat, Alain
    Berthe, Pauline
    Auffret, Vincent
    Dupuy, Alain
    Oger, Emmanuel
    Droitcourt, Catherine
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 18 - 18
  • [4] The Rate of Infections With Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-Analysis
    Tarafdar, Nawar
    Sachdeva, Muskaan
    Dubale, Natnaiel M.
    Smythe, Ciaran
    Lytvyn, Yuliya
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) : 83 - 85
  • [5] Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis
    Chen, Bai-lin
    Huang, Shan
    Dong, Xiao-wan
    Wu, Dou-dou
    Bai, Yan-ping
    Chen, Yuan-yuan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [6] The effectiveness of Janus kinase inhibitors in treating atopic dermatitis: A systematic review and meta-analysis
    Arora, Charan Jeet
    Khattak, Fakhre Alam
    Yousafzai, Mohammad Tahir
    Ibitoye, Bukola Mary
    Shumack, Stephen
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [7] The efficacy of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and network meta-analysis
    Zhang, Lu
    Wang, Lian
    Jiang, Xian
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [8] The efficacy and safety of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and meta-analysis
    Chen, Jingsi
    Cheng, Jun
    Yang, Huan
    Tu, Wei
    Zhang, Yan
    Luo, Xiaoyan
    Wang, Hua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 495 - 496
  • [9] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1923 - 1933
  • [10] Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
    Li, Chenyang
    Sun, Xun
    Zhao, Kun
    Meng, Fanxiang
    Li, Lin
    Mu, Zhenzhen
    Han, Xiuping
    DERMATOLOGY, 2022, 238 (04) : 725 - 735
12345